Clinical presentation and analysis of risk factors for infectious complications of implantable cardioverter-defibrillator implantations at a university medical center

Clinical Infectious Diseases

Volumn 26, Issue 5, 1998, Pages 1111-1116

  Spinier, Sarah A ^a   Nawarskas, James J ^b   Foote, Edward F ^b   Sabapathi, Durai ^b   Connors, John E ^b   Marchlinski, Francis E ^b  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFALEXIN; CEPHALOSPORIN; CIPROFLOXACIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DEFIBRILLATOR; DIABETES MELLITUS; FEMALE; HUMAN; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STERNOTOMY; THORACOTOMY;

EID: 0031925767     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520299     Document Type: Article

References (20)

1. Trappe HJ, Pfitzner P, Heintze J, et al. Cardioverter-defibrillator implantation in the catheterization laboratory: initial experiences in 48 patients. Am Heart J 1995;129:259-64.
2. Zipes DP, Roberts D, Pacemaker-Cardioverter-Defibrillator Investigators. Results of the International Study of the Implantable Pacemaker Cardioverter-Defibrillator. A comparison of epicardial and endocardial lead systems. Circulation 1995;92:59-65.
3. Bakker PFA, Hauer RNW, Wever EFD. Infections involving implanted cardioverter defibrillator devices. PACE 1992;15:654-8.
4. Borbola J, Denes P, Ezri MD, Hauser RG, Serry C, Goldin MD. The automatic implantable cardioverter-defibrillator: clinical experience, complications, and follow-up in 25 patients. Arch Intern Med 1988;148:70-6.
5. Katona P, Wiener I, Saxena N. Mycobacterium avium-intracellulare infection of an automatic implantable cardioverter defibrillator. Am Heart J 1992;124:1380-1.
6. Dunn CJ, Ruder M, Deresinski SC. Aspergillus fumigatus infection of an automatic internal cardiac defibrillator. PACE 1996;19:2156-7.
7. Stone DR, Estes NAM III, Klempner MS. Mycobacterium bovis infection of an implantable defibrillator following intravesical therapy with Bacille Calmette-Guérin. Clin Infect Dis 1993;16:825-6.
8. Spratt KA, Blumberg EA, Wood CA, Kutalek SP, Reboli AC. Infections of implantable cardioverter defibrillators: approach to management. Clin Infect Dis 1993;17:679-85.
9. Singer I. Complications of implantable cardioverter-defibrillator surgery: diagnosis and management. In: Singer I, ed. Implantable cardioverter defibrillator. Armonk, NY: Futura Publishing, 1994:415-32.
10. Smith PN, Hayes JJ, Vidaillet HJ Jr, et al. Infections with nonthoracotomy implantable cardioverter defibrillators: can these be prevented? [abstract]. PACE 1994;17(part 2):780.
11. Pinski SL, Trohman RG, Wilkoff BL, Morant VA, Sgarbossa EB, Shewchik J. Incidence and predictors of nonthoracotomy ICD system infection [abstract]. PACE 1995;18(part 2):1740.
12. Wunderly D, Maloney J, Edel T, McHenry M, McCarthy PM. Infections in implantable cardioverter defibrillator patients. PACE 1990;13(part 1):1360-4.
13. Dickinson GM, Bisno AL. Infections associated with indwelling devices: concepts of pathogenesis; infections associated with intravascular devices. Antimicrob Agents Chemother 1989;33:597-601.
14. Kennelly BM, Piller LW. Management of infected transvenous permanent pacemakers. Br Heart J 1974;36:1133-40.
15. Prophylaxis for elective surgery. In: Wilson RF, ed. Handbook of antibiotic therapy for surgery-related infections. 2nd ed. Springfield, NJ: Scientific Therapeutics Information, 1994:6-18.
16. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992;326:281-6.
17. Bigger JT Jr, Coronary Artery Bypass Graft (CABG) Patch Trial investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 1997;337:1569-75.
18. Kennergren C. Impact of implant techniques on complications with current implantable cardioverter-defibrillator systems. Am J Cardiol 1996;78(suppl 5A):15-20.
19. Gold MR, Peters RW, Johnson JW, Shorofsky SR, for the World-Wide Jewel Investigators. Complications associated with pectoral implantation of cardioverter-defibrillators. PACE 1997;20(part 2):208-11.
20. Mounsey JP, Griffith MJ, Tynan M, et al. Antibiotic prophylaxis in permanent pacemaker implantation: a prospective randomised trial. Br Heart J 1994;72:339-43.